The Medical and Regulatory Affairs team at NRx Pharmaceuticals is responsible for ensuring the scientific integrity and regulatory compliance of clinical programs. They provide strategic guidance on clinical development and regulatory submissions for key products like ZYESAMI and NRX-101, while advocating for patient needs and liaising with health authorities to facilitate the approval process and ensure safe and effective treatments.
View all